PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹4,842 Cr | ₹4,175 Cr | ₹3,903 Cr | ₹3,854 Cr | ₹3,252 Cr |
What is the latest Total Liabilities ratio of PFIZER ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹4,842 Cr |
| Mar2024 | ₹4,175 Cr |
| Mar2023 | ₹3,903 Cr |
| Mar2022 | ₹3,854 Cr |
| Mar2021 | ₹3,252 Cr |
How is Total Liabilities of PFIZER Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,842 Cr | 15.98 | |
| Mar2024 | ₹4,175 Cr | 6.96 | |
| Mar2023 | ₹3,903 Cr | 1.29 | |
| Mar2022 | ₹3,854 Cr | 18.48 | |
| Mar2021 | ₹3,252 Cr | - | |
Compare Total Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,806.0 Cr | 0.5% | -7.3% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 0.5% |
-7.3% |
15.4% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses